ZYBERNO
Stock Report
Updated Sep 1, 2026

Omada Health, Inc. (OMDA)

Healthcare • NASDAQ

$23.69

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
42.0/100
WEAK BUSINESS
Omada Health, Inc. (OMDA) scores 42/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-2.7%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-2.7%)
Return on Capital (Capital Efficiency):CRITICAL (-26.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Omada Health, Inc. (OMDA) stock report — Zyberno Score 42/100 (WEAK BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:23.69
Market Cap:$1.41B

Valuation Multiples (3)

P/B Ratio:5.59x
P/S Ratio:4.79x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$1.19B
Pfcf Ratio:83.52x

Price Action & Momentum (2)

% of 52-Week High:88.0%
B. Profitability Assessment

Return Metrics (5)

ROA:-2.0%
Reinvestment Rate:51.5%
Fundamental Growth Rate (g):-13.4%

Margin Analysis (3)

Operating Margin Ttm:-2.7%
Net Margin Ttm:-2.1%
Ebitda Margin:-2.5%

TTM Performance (3)

Gross Margin Ttm:67.0%
Operating Margin Ttm:-2.7%
Net Margin Ttm:-2.1%

Yield Metrics (2)

Earnings Yield:-$1.14
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):40.8%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.91x
Quick Ratio:3.85x
Cash Ratio:2.94x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-8.09x
Times Interest Earned:-8.09

Capital Structure (4)

Working Capital:219,428,000.00
Cash And Cash Equivalents:221,712,000.00
Long Term Debt:$0.00
Net Debt:-$221.71M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $295.28M
Linear Growth: 40.8%
📊 Click to view full OMDA Revenue analysis & methodology →
Cost Of Revenue Ttm:$97.43M

Profitability Breakdown (2)

Gross profit TTM: $197.86M
Linear Growth: 49.0%
📊 Click to view full OMDA Gross Profit analysis & methodology →
-$8.09M

Bottom Line Performance (3)

-$6.17M
Income Before Tax:-$6.17M
Ebitda Ttm:-7,389,000.00

Operating Expenses (5)

Operating Expenses:205,946,000.00
R And D Expense:47,647,000.00
Sga Expense:56,363,000.00
Income Tax Expense:$0.00
Interest Expense:1,479,000.00

Expense Ratios (3)

R And D To Revenue Percentage:54.2%
Sga To Revenue Percentage:64.2%
Ebitda Margin:-2.5%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$328.22M
Current Assets:$294.91M
Ppe Net:9,098,000.00
Goodwill:13,240,000.00
Intangible Assets:$1.54M

Liability Structure (4)

Total Liabilities:75,483,000.00
Current Liabilities:75,483,000.00
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$252.74M
Retained Earnings:-$454.42M
Common Stock:750,000,000.00

Working Capital Items (3)

Accounts Receivable:56,573,000.00
Inventory:4,119,000.00
Accounts Payable:35,978,000.00

Special Items (2)

Contract Liabilities:27,701,000.00
Stock Based Compensation:5,631,000.00
C. Cash Flow Analysis

Operating Activities (2)

$18.25M$16.93M

Investment Activities (1)

Investing Cash Flow:-$1.56M

Financing Activities (3)

Financing Cash Flow:$3.12M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:700,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.26
-$0.27
Earnings Per Share Ttm:-$0.10

Revenue & Cash Per Share (2)

Sales Per Share Ttm:4.95
Operating Cash Flow Per Share:$0.31

Book Value & Capital (2)

Book Value Per Share:$4.23
Cash Per Share:3.71

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.97x
Working Capital Turnover Ttm:1.35x

Receivables Management (2)

Receivables Turnover Ttm:5.22x
Days Sales Outstanding Ttm:69.93

Inventory Management (2)

Inventory Turnover Ttm:23.65x
Days Inventory Outstanding Ttm:15.43

Payables & Cash Cycle (2)

Days Payable Outstanding:134.79
Cash Conversion Cycle:-49.43
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:50.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:51.5%
Fundamental Growth Rate (g):-13.4%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):40.8%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):49.0%
Book Value Growth Rate (Linear):17.6%
C. Company Profile & Context

Corporate Information (6)

Symbol:OMDA
Company Name:Omada Health, Inc.
Sector:Healthcare
Industry:Healthcare Services
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:medium
Volume Category:N/A

Share Structure (3)

Shares Outstanding:59.69M
Shares Outstanding Basic:59.69M
Shares Outstanding Diluted:63.95M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 01:18:02 UTC
Data Timestamp:2026-09-01T01:18:02.625560
Scroll to Top